NRG Oncology

03/16/2026

The NRG-GI008 CIRCULATE-North America study is trying to determine whether chemotherapy is needed for all or only some high-risk stage II colon cancer patients & if chemotherapy is needed, what kind to recommend to patients based on the presence or absence of ctDNA following surgery for colon cancer.

03/14/2026

March is . If you are age 45 and at average risk, now is the time to get screened. Colonoscopy is considered the "gold standard" to detect & prevent cancer, typically done every 10 years, while annual, less-invasive, at-home stool tests are also highly recommended according the CDC.

03/13/2026

Check out the latest FORTE Fridays eNewsletter! Get all the latest news & updates for clinical research professionals about this important prevention study. The FORTE Study
https://conta.cc/4snZZqn

03/12/2026

The NRG Oncology Early Career Mentorship Subcommittee is seeking applications for a 2-year Mentored Fellowship. Interested applicants should submit the electronic application, cover letter & a copy of their CV by 5pm ET on April 30, 2026. Learn more: https://conta.cc/4szn2ym

03/11/2026

Reminder: NRG-CC008 (SOROCk) is recruiting participants with BRCA1 mutation who are considering surgery to reduce their risk of developing ovarian cancer. Please continue to review your patient population & discuss enrollment opportunities with your clinical teams.

03/10/2026

Attn sites that have NRG-BR009 (OFSET) open or are interested in opening this trial: a webinar on Thursday, March 12, 2026 is scheduled to discuss the study. Please refer to the memo on CTSU, dated January 19, 2026 for more information and how to register for the session.

03/07/2026

Don't forget to Spring Forward tonight! What will you do with your "extra" hour of daylight tomorrow? You could make a plan to schedule a . Current guidelines recommend screening for starting at age 45 for people at average risk.

03/06/2026

🌟Happy Employee Appreciation Day!🎉Today, we recognize & thank the staff of NRG Oncology. Their dedication, expertise & collaborative spirit drive our mission forward every day.

03/05/2026

NOW LIVE! 2025-2026 AMA President Dr. Mukkamala and Dartmouth Cancer Center / JNCI Spectrum Editor-in-Chief Dr. Yu discuss all this Health Policy, Access, and using Patient-Reported Outcomes in today's podcast episode. Tune in & share: www.NRGOncology.org/Podcast

03/04/2026

In light of recent news indicating that deaths from are increasing in people under 50, we thought it would be a good time to revisit our interview with Dr. Thom George as he discussed treatment options & NRG's portfolio of for patients with colorectal cancer. (COBRA & JANUS are closed to patient enrollment.)

Dr. Thomas George, Chair of the NRG Gastrointestinal Colorectal Committee - discusses the committee and their current portfolio during an interview at NRG202...

03/03/2026

The SOROCk trial is comparing the effects of two surgical procedures in risk reduction in women with BRCA1 mutations. Visit the SOROCk FAQ section and the Patient Study Brochure posted on our website to learn more: https://nrgoncology.org/SOROCk

03/03/2026

NRG issued a special broadcast outlining all committee leadership changes that became effective on March 1, 2026: https://conta.cc/4l4yyzp